#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue sarcoma Drug eruption Amyloidosis Neuroblastoma recurrent Uterine leiomyosarcoma Herpes simplex Breast cancer Adenovirus infection Von Willebrand's disease Mastocytosis Immune-mediated myositis Alexander disease Polyneuropathy Paget's disease of the vulva Sarcoidosis More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Life with Disease Acquired haemophilia Acquired haemophilia – Basic Information Systemic mastocytosis – Trials in Disease Primary biliary cholangitis – Treatment Rett syndrome – Trials in Disease Marginal zone lymphoma – Life with Disease Acquired haemophilia – Treatment Usher’s syndrome – Basic Information Pituitary-dependent Cushing’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Botaretigene Sparoparvovec Tranexamic Acid Linsitinib Fezolinetant Ozanimod Hydrochloride Carbetocin Ceftriaxone Gen1047 Dimethyl Fumarate Iron Sucrose Tafamidis Pemigatinib Keto-Isoleucine Calcium Rondaptivon Pegol Tng462 Mosaic Hbcoreag Suxamethonium Chloride Streptococcus Pneumoniae CARBOMER 980 Litenimod Sodium More therapies…

    Learn about Your Condition

    Hypophosphatasia Drug dependence Adenocarcinoma of colon Cardiogenic shock Adenosquamous cell lung cancer Splenic marginal zone lymphoma Pseudoxanthoma elasticum Plasma cell myeloma Endocrine disorder Breast cancer metastatic Primary myelofibrosis Prostate cancer metastatic Leukaemia Amyloidosis Chronic coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glucose tolerance impaired

  • Study of dapagliflozin and semaglutide to reverse prediabetes to normal blood sugar levels in patients with coronary artery disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    • Coronary artery disease
    Investigated Drugs:
    • Dapagliflozin
    • Semaglutide
    Denmark

  • Evaluation of controlled-ileal-release nicotinic acid tablets compared to placebo for treating people with prediabetes

    Recruiting

    2 1
    Germany

  • Study of Pioglitazone and Metformin combination treatment for patients with Metabolic Associated Fatty Liver Disease and prediabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    • Glucose tolerance impaired
    Investigated Drugs:
    • Pioglitazone
    • Metformin Hydrochloride
    Spain

  • Study on the Safety and Effectiveness of Tregs and Rituximab for Children with Early Stage Type 1 Diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Clemastine Fumarate
    • Poltreg-T1D
    • Saline
    Poland

  • Study on the Effects of Semaglutide, Dapagliflozin, and Metformin in Patients with Coronary Artery Disease and Prediabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Glucose tolerance impaired
    • Coronary artery disease
    Investigated Drugs:
    • Metformin Hydrochloride
    • Dapagliflozin
    • Semaglutide
    Poland

  • Study of Semaglutide for Treating Prediabetes in Women with Previous Gestational Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Semaglutide
    Belgium
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!